Keywords: cytel, mi, drug, disappoints, phase, ii, announced

Cytel's MI Drug Disappoints In Phase II

Article | 10 June 1996

Print This

Cytel has announced the termination of a Phase II clinical study with its carbohydrate-based cell adhesion blocker, Cylexin. The study ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in